Sep 24, 2018 - Stock markets have rallied strongly this year, with all three centralized stock benchmarks hitting recent records.But the healthcare sector has been a standout in this environment, and the recent brea
Sep 23, 2018 - Pfizer and AbbVie registered debt offerings with the SEC for $5bn and $6bn respectively, while Bristol-Myers sits tight on a recent shelf offering.AbbVie reigns as debt queen, looking to refinance the
Sep 21, 2018 - The index made strong gains this week as investors shrugged off trade tensions.
Sep 20, 2018 - Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.
Sep 20, 2018 - Arvinas Holding aims to sell $100 million of its common stock in a U.S. IPO.The firm is advancing a pipeline of drug candidates for the treatment of various cancers.Although still a very early stage c
Sep 20, 2018 - Lilly (LLY) prices Elanco IPO at $24 per share which is above the expected range of $20-$23 per share.
Sep 19, 2018 - Johnson & Johnson (JNJ) submits regulatory application to the FDA seeking approval of pan-FGFR inhibitor, erdafitinib, for the treatment of metastatic urothelial cancer, a type of bladder cancer.
Sep 18, 2018 - Alnylam had an eventful week.Karyopharm reports positive Phase 2 data.Teva’s migraine drug is approved.
Sep 18, 2018 - Pfizer's (PFE) latest anti-PD-L1 immunotherapy, Bavencio, is being touted as a significant long-term top-line driver for the company.
Sep 17, 2018 - Glaxo (GSK) submits a regulatory application in the EU for a single-tablet, two-drug regimen of dolutegravir and lamivudine for the first-line treatment of HIV-1 infection.